好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Steroid Un-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SUEAT) in Pediatric Patients.
Autoimmune Neurology
P2 - Poster Session 2 (9:00 AM-3:00 PM)
012
We report a series of children with encephalopathy associated with thyroid antibodies who are refractory to steroid monotherapy.
Steroid Responsive Encephalopathy associated with autoimmune thyroiditis (SREAT) is a rare condition, with only a few isolated cases reported in children. Marked clinical improvement following treatment with steroids, is a hallmark of SREAT.
An IRB approved chart review was conducted on patients <18 years diagnosed with autoimmune encephalitis. A retrospective analysis of clinical features, diagnostic tests, response to therapy and long term follow up was conducted on patients positive for Thyroperoxidase (TPO) antibodies.  

52 patients <18 years were diagnosed with autoimmune encephalitis, 10 (19.2%) of these were positive for TPO antibodies. Median age at disease onset was 14.5 years (range 6-18 years) with only 1 male patient being. Mental status (90%) and behavior changes (100%) were most common presentations, seizures were detected in only 1 patient. MRI (20%) and EEG (30%) abnormalities were uncommon, and only 1 patient had evidence of inflammation in cerebrospinal fluid (CSF). Autoimmune encephalitis and paraneoplastic antibody panels were negative besides 2 (20%) patients having concomitant Thyroglobulin (TG) antibodies. All patients needed additional IVIG after steroids treatment, 7(70%) patients received Rituximab and 3(30%) patients needed Plasmapheresis. All patients recovered at an average of 4.4 years follow up.

Encephalopathy associated with thyroid antibodies can be steroid unresponsive in the pediatric population. Further immune therapy, including plasmapheresis, should be considered in these patients, even in the absence of other para-clinical evidence of inflammation.

Authors/Disclosures
Geetanjali S. Rathore, MD, FAAN (Childrens NEBRASKA)
PRESENTER
Dr. Rathore has nothing to disclose.